This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Influenza mRNA Vaccines
April 27, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Raffael Nachbagauer
Program Leader & Executive Director, Infectious Disease Development at Moderna, USA

Agenda Sessions

  • Development of mRNA-Based Seasonal Influenza Vaccines

    , 10:05am
    View Session

Speakers at this event

Prev
Next
Norbert Pardi
Research Assistant Professor of Medicine
University of Pennsylvania, USA

See Raffael Speak